Stock Updates

Today’s Top Gainers in the Market Teva Pharmaceutical Industries Limited (NYSE:TEVA) from Healthcare

Today’s top gainers include the company Teva Pharmaceutical Industries Limited (NYSE:TEVA) which is in the industry Drug Manufacturers – Other, gaining -0.04% today. In the last week its performance is -1.40%, and -13.59% for the past quarter. Currently, Teva Pharmaceutical Industries Limited, TEVA has a target price of 67.91, so today’s gain of -0.04% is a significant step towards its target price. The GAP today is therefore 1.55%.

Teva Pharmaceutical Industries Limited (NYSE:TEVA), has a market cap of 46404.71, and is based in Israel. Insider ownership is at 2.70%, and institutional ownership is 59.30%.

At the current price of 45.04, it has a dividend yield of 3.02%, and its target price is 67.91. This is with a profit margin of 6.90%, and total debt/equity of 0.36. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a P/E of 30.07, as well as a forward P/E of 7.62.

With a current EPS of 1.5, and a forecasted EPS growth for next year at 13.01%,Teva Pharmaceutical Industries Limited (NYSE:TEVA) has had a EPS growth for the past five years at -13.10%. For the next five years EPS growth is projected to be 4.56%.

Performance for the year is -21.68%. Since its IPO date on 3/26/1990, the total performance to date is -30.06%.

Volume today for Teva Pharmaceutical Industries Limited (NYSE:TEVA), is 6855700, while its average volume is 6380.4. Whilst the total gain today was -0.04%, it did have a day high of -18.75%.

Volatility for this week has been at 2.16%, and 2.19% for the month. The 52-week low for Teva Pharmaceutical Industries Limited, TEVA has been 0.99%, while the 52-week-high has reached -31.02%.

Looking at its return of investments, which is 5.70%, and its return on assets is 2.50%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an operating margin of 17.70%. With a sales growth of 1.40% quarter over quarter. Bearing in mind that Teva Pharmaceutical Industries Limited, TEVA is in the sector Healthcare, its long-term debt/equity is 0.27, and has a current ratio of 1.3 and 1 for quick ratio.

So what is the value of Teva Pharmaceutical Industries Limited? Well its PEG is 6.59, and the P/S is 2.37, along with a P/B of 1.37. Meanwhile it has a p/cash of 6.64.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment